Positive-Strand RNA Viruses: Mechanisms of Viral Pathogenesis, Host Immunity, and Countermeasures (F1)
September 20-24, 2027
| Location to be Determined
David R. Martinez, Eng Eong Ooi and Yoke Fun Chan
Monday, September 20, 2027
| 4:00–8:00 PM |
Registration |
|
| 6:00–8:00 PM |
Welcome Mixer |
|
Tuesday, September 21, 2027
| 8:00–8:10 AM |
Welcome Remarks (Joint) |
|
| 8:10–9:00 AM |
Keynote Address (Joint) |
|
| |
Raul Andino †, University of California, San Francisco
Virus Evolution and Live-Attenuated Viral Vaccines |
|
| 9:00–11:15 AM |
Spillover Risk, Surveillance, and Potential from Animals to Humans (Joint) |
|
| |
Le Van Tan †, Oxford University Clinical Research Unit
Viral Surveillance: What Probing Nature Teaches Us About Pandemic Preparedness |
|
| |
Michael S. Diamond †, Washington University School of Medicine
Zoonotic Reservoirs, Spillover Mechanisms, and Surveillance of Emerging Positive-Strand RNA Viruses |
|
| |
Cleo Bertelsmeier †, University of Lausanne
Wildlife Trade Drives Animal-to-Human Pathogen Transmission |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:30–9:50 AM |
Coffee Break |
|
| 11:15–1:00 PM |
Poster Setup |
|
| 11:15–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 2:30–4:30 PM |
Symposia Spotlight 1: Viral Surveillance to Inform Pandemic Preparedness |
|
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
The Replication Machinery: Insights from RNA and Protein Synthesis into Viral Co-Opting of Host Processes |
|
| |
Montserrat Barcena †, Leiden University Medical Center
Host Cell Membrane Remodeling and Cellular Organelle Hijacking |
|
| |
Shin-Ru Shih †, Chang Gung University
Host Translation Shutoff and Cellular Metabolic Reprogramming |
|
| |
Yue Wan †, Genome Institute of Singapore
Mapping Long-Range Viral RNA-RNA Interactions |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
Wednesday, September 22, 2027
| 8:00–11:00 AM |
AI in Infectious Disease Research (Joint) |
|
| |
Ethan Jackson †, Microsoft
Project Premonition: Reimagining Pathogen Surveillance with AI, Robotics, and Genomics |
|
| |
Aude Bernheim †, Institut Pasteur
Evolution of Immunity Across Domains of Life |
|
| |
David Baker †, University of Washington
Design of New Antibodies Using Deep Learning |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–1:00 PM |
Poster Setup |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 3:00–4:30 PM |
Career Roundtable |
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Viral Pathogenesis Determinants in Mammalian and Mosquito Hosts |
|
| |
Craig B. Wilen †, Yale University
Norovirus infection and Pathogenesis |
|
| |
Gisa Gerold †, Medical University of Innsbruck-Institute of Virology
Alphavirus Pathogenesis Mechanisms in Mammals and Mosquitoes |
|
| |
Gong Cheng †, Tsinghua University
Mosquito Host-Viral Interactions in Orthoflavivirus Infection |
|
| |
Yoke Fun Chan, University Malaya
Mechanisms of Pathogenesis of Picornaviruses |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
Thursday, September 23, 2027
| 8:00–11:00 AM |
Countermeasures: Recent Advances in Vaccines to Positive-Stranded RNA Viruses |
|
| |
David R. Martinez, Yale University School of Medicine
Vaccination Strategies Against RNA Viruses |
|
| |
Long Ping Victor Tse †, Saint Louis University
Using Directed Evolution to Inform Live-Attenuated Dengue Vaccines that Bypass Antibody-Dependent Enhancement |
|
| |
Eng Eong Ooi, Duke-NUS Medical School
Dengue Virus Vaccines |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:10–12:10 PM |
Panel Discussion: Bridging Basic Virology to Clinical Post-Acute Care |
|
| 12:10–5:00 PM |
On Own for Lunch |
|
| 2:30–4:30 PM |
Symposia Spotlight 2: Countermeasure Development in a Post-Pandemic World |
|
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–6:45 PM |
Targeting the Virus: Small Molecules and Biologics to Counter Viral Disease |
|
| |
Priscilla L. Yang †, Stanford University School of Medicine
Orthoflavivirus Antivirals: Current Landscape and Future Targets |
|
| |
Sara R. Cherry †, University of Pennsylvania
Clinical Development of Antivirals Against Emerging and Re-Emerging RNA Viruses |
|
| |
Camila H Coelho †, Icahn School of Medicine at Mount Sinai
Broadly Cross-Reactive Immunity Against Emerging Coronaviruses and Flaviviruses |
|
| |
Tomas Cihlar †, Gilead Sciences, Inc.
Preclinical and Clinical Development of Antivirals |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 6:45–7:00 PM |
Meeting Wrap-Up: Outcomes and Future Directions |
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 PM |
Entertainment |
|
Friday, September 24, 2027
